❮ Back to Researchers

Yvonne Bombard

PhD, BSc

Scientist

Email: Yvonne.Bombard@unityhealth.to
Tel: 416-864-6060 ext. 77378
LinkedIn: Yvonne Bombard
Twitter: @yvonnebombard

Labs

Yvonne Bombard Lab ❯

Biography

Dr. Yvonne Bombard is a genomics health services researcher and Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health Toronto. She is an Associate Professor at the Institute of Health Policy, Management and Evaluation at the University of Toronto and directs the Genomics Health Services Research Program at St. Michael’s Hospital. Dr. Bombard holds the Canada Research Chair in Genomics Health Services and Policy. She sets research direction at national and international levels as Board Member of the American Society of Human Genetics and CIHR’s Institute of Genetics. Dr. Bombard advises on funding recommendations on emerging genetic testing technologies for Ontario. Dr. Bombard was the inaugural recipient of the Maurice McGregor Award for Demonstrated Excellence and Leadership Potential from the Canadian Agency for Drugs and Technologies in Health (CADTH) and also received a ‘Rising Star’ award from CIHR’s Institute of Health Services and Policy Research. She has been awarded a CIHR Foundation grant as an Early Career Investigator, CIHR Maud Menten Early Career Prize in Genetics and recently received Canadian Cancer Society’s early career investigator award for her work and policy change.

Recent Publications

  1. Friedman, JM, Bombard, Y, Carleton, B, Issa, AM, Knoppers, B, Plon, SE et al.. Should Secondary Pharmacogenomic Variants Be Actively Screened and Reported When Diagnostic Genome-Wide Sequencing Is Performed in a Child?. Genet Med. 2023; :101033. doi: 10.1016/j.gim.2023.101033. PubMed PMID:38007624 .
  2. Husereau, D, Bombard, Y, Stockley, T, Carter, M, Davey, S, Lemaire, D et al.. Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective. Curr Oncol. 2023;30 (11):9660-9669. doi: 10.3390/curroncol30110700. PubMed PMID:37999120 PubMed Central PMC10670221.
  3. Di Carlo, C, Mighton, C, Clausen, M, Joshi, E, Casalino, S, Kim, THM et al.. Parents' attitudes towards research involving genome sequencing of their healthy children: a qualitative study. Eur J Hum Genet. 2023; :. doi: 10.1038/s41431-023-01476-9. PubMed PMID:37864046 .
  4. Adi-Wauran, E, Clausen, M, Shickh, S, Gagliardi, AR, Denburg, A, Oldfield, LE et al.. "I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening. Eur J Hum Genet. 2023; :. doi: 10.1038/s41431-023-01473-y. PubMed PMID:37821757 .
  5. Farncombe, KM, Wong, D, Norman, ML, Oldfield, LE, Sobotka, JA, Basik, M et al.. Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy. Am J Hum Genet. 2023;110 (10):1616-1627. doi: 10.1016/j.ajhg.2023.08.014. PubMed PMID:37802042 PubMed Central PMC10577078.
  6. Morgan, G, Casalino, S, Chowdhary, S, Frangione, E, Fung, CYJ, Haller, S et al.. Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study. Viruses. 2023;15 (8):. doi: 10.3390/v15081764. PubMed PMID:37632107 PubMed Central PMC10457914.
  7. Shickh, S, Mighton, C, Clausen, M, Kodida, R, Adi-Wauran, E, Hirjikaka, D et al.. "I don't need any more unknowns hanging over my head": Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing. Genet Med. 2023;25 (12):100960. doi: 10.1016/j.gim.2023.100960. PubMed PMID:37577963 .
  8. Morgan, G, Briollais, L, Clausen, M, Casalino, S, Mighton, C, Chowdhary, S et al.. Public knowledge of SARS-CoV-2 serological and viral lineage laboratory testing and result interpretation: A GENCOV study cross-sectional survey. Clin Biochem. 2023;118 :110607. doi: 10.1016/j.clinbiochem.2023.110607. PubMed PMID:37406717 .
  9. Shickh, S, Leventakos, K, Lewis, MA, Bombard, Y, Montori, VM. Shared Decision Making in the Care of Patients With Cancer. Am Soc Clin Oncol Educ Book. 2023;43 :e389516. doi: 10.1200/EDBK_389516. PubMed PMID:37339391 .
  10. Allyse, MA, Meagher, KM, Michie, M, Isasi, R, Ormond, KE, Bonhomme, N et al.. Translational Justice in Human Gene Editing: Bringing End User Engagement and Policy Together. Am J Bioeth. 2023;23 (7):55-58. doi: 10.1080/15265161.2023.2207513. PubMed PMID:37339310 PubMed Central PMC10441003.
Search PubMed

Affiliations & Other Activities

  • Associate Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Member, Board of Directors, American Society of Human Genetics
  • Member, CIHR Institute of Genetics Advisory Board
  • Member, Ontario Genetics Advisory Committee, Health Quality Ontario
  • Member, Board of Directors, Exactis Innovation
  • Associate, Ontario Institute of Cancer Research
  • Co-lead, Societal Values and Patient Engagement Program, the Canadian Centre for Applied Research in Cancer Control
  • Member, Provincial Council for Maternal and Child Health’s Prenatal Screening Advisory Committee
  • Member, Steering Committee of the Canadian Coalition for Genetic Fairness